News

Personalized nutrition refers to the practice of tailoring dietary plans to an individual's needs rather than the general population's. Customized nutrition plans consider an individual's age, sex, genetics, and health objectives. More people are becoming aware that a one-fit-all...

BCAA supplements are increasingly gaining popularity amongst athletes and people involved in resistance training. These supplements are typically consumed before, during, or after exercise. Scientific studies have shown that consuming BCAAs reduces muscle damage and increases muscle protein synthesis. Here, we...

Astellas Pharma Inc., Eisai Co., Daiichi Sankyo Company and Takeda Pharmaceutical have agreed on collaboration to reduce environmental burden in the field of pharmaceutical packaging. Based on the agreement, the four companies will aim to promote the use of more...

Rhenus Air & Ocean’s pharma-focused business site at Amsterdam Airport Schiphol (AMS) has gained the Good Distribution Practice (GDP) certificate. The Dutch headquarters of Rhenus, which has been IATA CEIV Pharma accredited for years, follows the footsteps of the business...

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval from Health Canada to initiate its Phase 1/2a study evaluating the safety, tolerability, bioavailabilty...

Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a strategic collaboration. Both parties aim to share resources and achieve joint development on the principle of equality and...

Eli Lilly and Company and ProQR Therapeutics N.V. announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization of new genetic medicines. The collaboration, originally announced in September 2021, applied ProQR’s proprietary Axiomer® RNA editing...